| Reaction Details |
|---|
 | Report a problem with these data |
| Target | C-C chemokine receptor type 3 |
|---|
| Ligand | BDBM50254448 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_560250 (CHEMBL1019589) |
|---|
| IC50 | 0.47±n/a nM |
|---|
| Citation |  Dhar, TG; Yang, G; Davies, P; Malley, MF; Gougoutas, JZ; Wu, DR; Barrish, JC; Carter, PH Urea based CCR3 antagonists employing a tetrahydro-1,3-oxazin-2-one spacer. Bioorg Med Chem Lett19:96-9 (2008) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| C-C chemokine receptor type 3 |
|---|
| Name: | C-C chemokine receptor type 3 |
|---|
| Synonyms: | C-C CKR-3 | C-C chemokine receptor type 3 (CCR3) | CC-CKR-3 | CCR-3 | CCR3 | CCR3_HUMAN | CD_antigen=CD193 | CKR3 | CMKBR3 | Eosinophil eotaxin receptor |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 41053.88 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P51677 |
|---|
| Residue: | 355 |
|---|
| Sequence: | MTTSLDTVETFGTTSYYDDVGLLCEKADTRALMAQFVPPLYSLVFTVGLLGNVVVVMILI
KYRRLRIMTNIYLLNLAISDLLFLVTLPFWIHYVRGHNWVFGHGMCKLLSGFYHTGLYSE
IFFIILLTIDRYLAIVHAVFALRARTVTFGVITSIVTWGLAVLAALPEFIFYETEELFEE
TLCSALYPEDTVYSWRHFHTLRMTIFCLVLPLLVMAICYTGIIKTLLRCPSKKKYKAIRL
IFVIMAVFFIFWTPYNVAILLSSYQSILFGNDCERSKHLDLVMLVTEVIAYSHCCMNPVI
YAFVGERFRKYLRHFFHRHLLMHLGRYIPFLPSEKLERTSSVSPSTAEPELSIVF
|
|
|
|---|
| BDBM50254448 |
|---|
| n/a |
|---|
| Name | BDBM50254448 |
|---|
| Synonyms: | 1-(6-((ethyl(3-(4-fluorophenyl) propyl)amino)methyl)-3,5-dimethyl-2-oxo-1,3-oxazinan-5-yl)-3-(3-(1-methyl-1H-tetrazol-5-yl)phenyl)urea | 1-(6-((ethyl(3-(4-fluorophenyl)propyl)amino)methyl)-3,5-dimethyl-2-oxo-1,3-oxazinan-5-yl)-3-(3-(1-methyl-1H-tetrazol-5-yl)phenyl)urea | CHEMBL461445 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C27H35FN8O3 |
|---|
| Mol. Mass. | 538.617 |
|---|
| SMILES | CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(c1)-c1nnnn1C |
|---|
| Structure | 
|
|---|
Search and Browse
